Cuffless monitor offers promise for hypertension management

Gilead and Ar­cel­lx’s ear­ly tri­al da­ta on their mul­ti­ple myelo­ma cell ther­a­py show that pa­tients saw no cas­es of cer­tain de­layed neu­ro­tox­i­c­i­ties, which are as­so­ci­at­ed

All women ages 65 and older and at-risk postmenopausal women under 65 should be screened for osteoporosis to prevent fractures, according to a final recommendation